Hydrogen sulfide protects endothelial nitric oxide function under conditions of acute oxidative stress in vitro
- PMID: 24068103
- DOI: 10.1007/s00210-013-0920-x
Hydrogen sulfide protects endothelial nitric oxide function under conditions of acute oxidative stress in vitro
Abstract
The aim of this study was to examine the ability of H2S, released from NaHS to protect vascular endothelial function under conditions of acute oxidative stress by scavenging superoxide anions (O2(-)) and suppressing vascular superoxide anion production. O2(-) was generated in Krebs' solution by reacting hypoxanthine with xanthine oxidase (Hx-XO) or with the O2(-) generator pyrogallol to model acute oxidative stress in vitro. O2(-) generation was measured by lucigenin-enhanced chemiluminescence. Functional responses in mouse aortic rings were assessed using a small vessel myograph. NaHS scavenged O2(-) in a concentration-dependent manner. Isolated aortic rings exposed to either Hx-XO or pyrogallol displayed significantly attenuated maximum vasorelaxation responses to the endothelium-dependent vasodilator acetylcholine, and significantly reduced NO bioavailability, which was completely reversed if vessels were pre-incubated with NaHS (100 μM). NADPH-stimulated aortic O2(-) production was significantly attenuated by the NADPH oxidase inhibitor diphenyl iodonium. Prior treatment of vessels with NaHS (100 nM-100 μM; 30 min) inhibited NADPH-stimulated aortic O2(-) production in a concentration-dependent manner. This effect persisted when NaHS was washed out prior to measuring NADPH-stimulated O2(-) production. These data show for the first time that NaHS directly scavenges O2(-) and suppresses vascular NADPH oxidase-derived O2(-) production in vitro. Furthermore, these properties protect endothelial function and NO bioavailability in an in vitro model of acute oxidative stress. These results suggest that H2S can elicit vasoprotection by both scavenging O2(-) and by reducing vascular NADPH oxidase-derived O2(-) production.
Similar articles
-
Chronic NaHS treatment decreases oxidative stress and improves endothelial function in diabetic mice.Diab Vasc Dis Res. 2017 May;14(3):246-253. doi: 10.1177/1479164117692766. Epub 2017 Feb 1. Diab Vasc Dis Res. 2017. PMID: 28467198
-
Mechanism of vasorelaxation and role of endogenous hydrogen sulfide production in mouse aorta.Naunyn Schmiedebergs Arch Pharmacol. 2011 Apr;383(4):403-13. doi: 10.1007/s00210-011-0608-z. Epub 2011 Feb 19. Naunyn Schmiedebergs Arch Pharmacol. 2011. PMID: 21336541
-
Hydrogen sulfide treatment reduces blood pressure and oxidative stress in angiotensin II-induced hypertensive mice.Hypertens Res. 2015 Jan;38(1):13-20. doi: 10.1038/hr.2014.125. Epub 2014 Aug 7. Hypertens Res. 2015. PMID: 25099489
-
Differential sensitivity of basal and acetylcholine-stimulated activity of nitric oxide to destruction by superoxide anion in rat aorta.Br J Pharmacol. 1995 Jul;115(6):993-1000. doi: 10.1111/j.1476-5381.1995.tb15909.x. Br J Pharmacol. 1995. PMID: 7582532 Free PMC article.
-
Hydrogen sulfide and endothelium-dependent vasorelaxation.Molecules. 2014 Dec 16;19(12):21183-99. doi: 10.3390/molecules191221183. Molecules. 2014. PMID: 25521118 Free PMC article. Review.
Cited by
-
High oxygen modifies vasodilator effect of cysteine via enhanced oxidative stress and thromboxane production in the rat mesenteric artery.Pflugers Arch. 2016 Sep;468(9):1555-64. doi: 10.1007/s00424-016-1857-y. Epub 2016 Jul 8. Pflugers Arch. 2016. PMID: 27389323
-
Urinary excretion of asymmetric (ADMA) and symmetric (SDMA) dimethylarginine is positively related to nitric oxide level in tissues of normotensive and hypertensive rats.Amino Acids. 2023 Apr;55(4):529-539. doi: 10.1007/s00726-023-03246-9. Epub 2023 Feb 19. Amino Acids. 2023. PMID: 36802034 Free PMC article.
-
Modes of physiologic H2S signaling in the brain and peripheral tissues.Antioxid Redox Signal. 2015 Feb 10;22(5):411-23. doi: 10.1089/ars.2014.5917. Epub 2014 May 9. Antioxid Redox Signal. 2015. PMID: 24684551 Free PMC article. Review.
-
Endogenous hydrogen sulfide improves vascular remodeling through PPARδ/SOCS3 signaling.J Adv Res. 2020 Jun 20;27:115-125. doi: 10.1016/j.jare.2020.06.005. eCollection 2021 Jan. J Adv Res. 2020. PMID: 33318871 Free PMC article. Review.
-
Hydrogen Sulfide Donor GYY4137 Protects against Myocardial Fibrosis.Oxid Med Cell Longev. 2015;2015:691070. doi: 10.1155/2015/691070. Epub 2015 May 11. Oxid Med Cell Longev. 2015. PMID: 26078813 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources